Kindly click on the Papers’ link titles below to read more.. Allergies Interventional procedure overview of intranasal phototherapy for allergic rhinitis Immunotherapy Safety and Immunological Changes During Sublingual Immunotherapy With Standardized Quality Grass Allergen Tablets Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: A double-blind, randomised study Specific Immunotherapy with High Dose SQ Standardized Grass Allergen Tablets was Safe and Well Tolerated Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy Once Daily Sublingual Immunotherapy without Updosing – A New Treatment Schedule Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children Multicenter Trial Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis Shorter Dosing Intervals of Sublingual Immunotherapy Lead to More Efficacious Treatment in a Mouse Model of Allergic Inflammation Observational study of sublingual specific immunotherapy in persistent and intermittent allergic rhinitis: the EFESO trial Randomized open comparison of the safety of SLIT in a no-updosing and traditional updosing schedule in patients with Parietaria allergy
